ICU Medical EBITDA Margin 2010-2025 | ICUI
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for ICU Medical (ICUI) over the last 10 years. The current EBITDA margin for ICU Medical as of March 31, 2025 is .
| ICU Medical EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-03-31 | $2.42B | $0.29B | 11.86% |
| 2024-12-31 | $2.38B | $0.27B | 11.34% |
| 2024-09-30 | $2.34B | $0.23B | 9.62% |
| 2024-06-30 | $2.30B | $0.24B | 10.50% |
| 2024-03-31 | $2.26B | $0.24B | 10.68% |
| 2023-12-31 | $2.26B | $0.26B | 11.47% |
| 2023-09-30 | $2.25B | $0.27B | 12.18% |
| 2023-06-30 | $2.29B | $0.25B | 10.94% |
| 2023-03-31 | $2.31B | $0.26B | 11.45% |
| 2022-12-31 | $2.28B | $0.23B | 9.91% |
| 2022-09-30 | $2.04B | $0.21B | 10.33% |
| 2022-06-30 | $1.78B | $0.21B | 11.90% |
| 2022-03-31 | $1.54B | $0.19B | 12.32% |
| 2021-12-31 | $1.32B | $0.21B | 16.25% |
| 2021-09-30 | $1.30B | $0.22B | 16.67% |
| 2021-06-30 | $1.28B | $0.20B | 15.48% |
| 2021-03-31 | $1.26B | $0.19B | 14.76% |
| 2020-12-31 | $1.27B | $0.18B | 14.48% |
| 2020-09-30 | $1.27B | $0.17B | 13.18% |
| 2020-06-30 | $1.26B | $0.18B | 14.18% |
| 2020-03-31 | $1.26B | $0.18B | 14.56% |
| 2019-12-31 | $1.27B | $0.19B | 14.61% |
| 2019-09-30 | $1.29B | $0.16B | 12.71% |
| 2019-06-30 | $1.31B | $0.13B | 10.00% |
| 2019-03-31 | $1.36B | $0.13B | 9.65% |
| 2018-12-31 | $1.40B | $0.10B | 7.43% |
| 2018-09-30 | $1.43B | $0.16B | 10.92% |
| 2018-06-30 | $1.45B | $0.15B | 10.31% |
| 2018-03-31 | $1.42B | $0.08B | 5.79% |
| 2017-12-31 | $1.29B | $0.05B | 4.18% |
| 2017-09-30 | $1.02B | $0.01B | 0.98% |
| 2017-06-30 | $0.77B | $0.02B | 3.10% |
| 2017-03-31 | $0.54B | $0.07B | 12.83% |
| 2016-12-31 | $0.38B | $0.10B | 27.11% |
| 2016-09-30 | $0.37B | $0.10B | 27.27% |
| 2016-06-30 | $0.36B | $0.10B | 28.37% |
| 2016-03-31 | $0.35B | $0.10B | 28.86% |
| 2015-12-31 | $0.34B | $0.09B | 26.10% |
| 2015-09-30 | $0.33B | $0.09B | 26.59% |
| 2015-06-30 | $0.32B | $0.07B | 22.67% |
| 2015-03-31 | $0.32B | $0.06B | 19.56% |
| 2014-12-31 | $0.31B | $0.06B | 19.42% |
| 2014-09-30 | $0.31B | $0.06B | 20.20% |
| 2014-06-30 | $0.31B | $0.07B | 22.04% |
| 2014-03-31 | $0.31B | $0.07B | 22.68% |
| 2013-12-31 | $0.31B | $0.07B | 23.25% |
| 2013-09-30 | $0.32B | $0.08B | 24.45% |
| 2013-06-30 | $0.32B | $0.08B | 25.24% |
| 2013-03-31 | $0.32B | $0.08B | 26.35% |
| 2012-12-31 | $0.32B | $0.08B | 26.18% |
| 2012-09-30 | $0.31B | $0.09B | 29.03% |
| 2012-06-30 | $0.31B | $0.09B | 27.87% |
| 2012-03-31 | $0.31B | $0.09B | 27.78% |
| 2011-12-31 | $0.30B | $0.09B | 28.24% |
| 2011-09-30 | $0.30B | $0.07B | 24.41% |
| 2011-06-30 | $0.30B | $0.07B | 24.75% |
| 2011-03-31 | $0.29B | $0.07B | 24.48% |
| 2010-12-31 | $0.28B | $0.07B | 22.97% |
| 2010-09-30 | $0.28B | $0.06B | 21.74% |
| 2010-06-30 | $0.25B | $0.05B | 20.87% |
| 2010-03-31 | $0.24B | $0.05B | 21.43% |
| 2009-12-31 | $0.23B | $0.05B | 23.68% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.213B | $2.382B |
| ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.390B | 27.94 |
| Boston Scientific (BSX) | United States | $154.114B | 38.58 |
| Stryker (SYK) | United States | $145.370B | 30.40 |
| EssilorLuxottica (ESLOY) | France | $128.999B | 0.00 |
| Medtronic (MDT) | Ireland | $107.400B | 15.23 |
| Haleon (HLN) | United Kingdom | $51.375B | 29.26 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.537B | 0.00 |
| ResMed (RMD) | United States | $35.781B | 26.88 |
| GE HealthCare Technologies (GEHC) | United States | $32.121B | 15.25 |
| Agilent Technologies (A) | United States | $31.661B | 20.57 |
| Terumo (TRUMY) | Japan | $27.316B | 35.48 |
| Insulet (PODD) | United States | $22.872B | 89.78 |
| Koninklijke Philips (PHG) | Netherlands | $21.440B | 15.41 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.026B | 11.58 |
| Baxter (BAX) | United States | $15.164B | 11.32 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.767B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $5.893B | 20.51 |
| Lantheus Holdings (LNTH) | United States | $5.336B | 13.46 |
| Prestige Consumer Healthcare (PBH) | United States | $4.224B | 18.87 |
| Perrigo (PRGO) | Ireland | $3.672B | 9.31 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.304B | 15.05 |
| Envista Holdings (NVST) | United States | $3.068B | 25.49 |
| GN Store Nord (GNNDY) | Denmark | $2.170B | 17.98 |
| QuidelOrtho (QDEL) | United States | $2.005B | 13.79 |
| LeMaitre Vascular (LMAT) | United States | $1.817B | 40.61 |
| AtriCure (ATRC) | United States | $1.683B | 0.00 |
| Acuren (TIC) | United States | $1.297B | 0.00 |
| Neogen (NEOG) | United States | $1.235B | 15.81 |
| AdaptHealth (AHCO) | United States | $1.181B | 11.99 |
| Green Thumb Industries (GTBIF) | United States | $1.143B | 25.71 |
| Kestra Medical Technologies (KMTS) | United States | $1.062B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.996B | 12.74 |
| BioLife Solutions (BLFS) | United States | $0.983B | 0.00 |
| InMode (INMD) | Israel | $0.907B | 9.14 |
| Evolus (EOLS) | United States | $0.643B | 0.00 |
| CeriBell (CBLL) | United States | $0.621B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.549B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.542B | 0.00 |
| Valneva SE (VALN) | France | $0.536B | 0.00 |
| Owens & Minor (OMI) | United States | $0.491B | 4.07 |
| Capricor Therapeutics (CAPR) | United States | $0.466B | 0.00 |
| Surmodics (SRDX) | United States | $0.421B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.410B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.366B | 0.00 |
| SNDL (SNDL) | Canada | $0.334B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.316B | 11.61 |
| Aurora Cannabis (ACB) | Canada | $0.293B | 52.10 |
| Cresco Labs (CRLBF) | United States | $0.289B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.259B | 21.87 |
| Sanara MedTech (SMTI) | United States | $0.259B | 0.00 |
| Cerus (CERS) | United States | $0.252B | 0.00 |
| ZimVie (ZIMV) | United States | $0.251B | 11.40 |
| Verano Holdings (VRNOF) | United States | $0.226B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.224B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.222B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.213B | 0.00 |
| Quanterix (QTRX) | United States | $0.204B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.197B | 0.00 |
| Biote (BTMD) | United States | $0.194B | 5.45 |
| Brainsway (BWAY) | Israel | $0.193B | 51.10 |
| High Tide (HITI) | Canada | $0.186B | 0.00 |
| Omeros (OMER) | United States | $0.180B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.178B | 14.48 |
| Organigram Global (OGI) | Canada | $0.175B | 0.00 |
| Exagen (XGN) | United States | $0.152B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.139B | 17.12 |
| Jin Medical (ZJYL) | China | $0.125B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.103B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.097B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.60 |
| MacroGenics (MGNX) | United States | $0.088B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| Agape ATP (ATPC) | $0.080B | 0.00 | |
| Quipt Home Medical (QIPT) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| ImmuCell (ICCC) | United States | $0.061B | 0.00 |
| Apyx Medical (APYX) | United States | $0.061B | 0.00 |
| Zynex (ZYXI) | United States | $0.061B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.060B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.054B | 0.00 |
| United Health Products (UEEC) | United States | $0.051B | 0.00 |
| Modular Medical (MODD) | United States | $0.043B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.29 |
| Rockwell Medical (RMTI) | United States | $0.034B | 0.00 |
| Nephros (NEPH) | United States | $0.033B | 44.71 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Safety Shot (SHOT) | United States | $0.020B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |